Release Date: 10/11/14 14:58 Summary: Proposed Corporate Restructure Price Sensitive: No Download Document 210.77KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling